You are here

Portage Biotech Inc.

Listing Exchange: 
CSE
Status: 
Active
Industry: 
Life Sciences
Symbol: 
PBT.U
CSE Index: 
Currency: 

Portage is engaged in researching and developing pharmaceutical and biotech products through to clinical "proof of concept" with an initial focus on unmet clinical needs and orphan drugs. Following proof of concept, Portage will look to sell or license the products to large pharmaceutical companies for further development and commercialization.

You are here

Portage Biotech Inc. (PBT.U)

SEDAR Information

Company Info

Address
47 Avenue Road, Suite 200
Toronto, ON M5R 2G3
Canada
Phone
416-929-1806
Fax
416-929-6612
Email
ks@portagebiotech.com
Listing date
Monday, October 28, 2013

Advertisement

Publicité

Capitalization

Issued & Outstanding: 
260,688,894
Reserved for Issuance: 
20,317,194

Company Officers

Dr. Declan Doogan, Chief Executive Officer and director
Kam Shah, Chief Financial Officer and director
Dr. Gregory Bailey, Chairman

Bulletins

08/02/2019

2019-0219 – Fundamental Change - Portage Biotech Inc. (PBT.U)

Le 8 février/February 2019

Portage Biotech Inc. has requalified for listing following a fundamental change.

Advertisement

Publicité

Latest CSE News

Upcoming Events

04_03_IIAC_Compliance_Operations_Symposium_Website

IIAC Compliance & Operations Symposium

Wednesday, April 3, 2019 (All day)
04_03_FFCON19_FEARLESS_Website_v2

FFCON19 FEARLESS

Wednesday, April 3, 2019 (All day) to Thursday, April 4, 2019 (All day)